Neogen (NEOG) Develops New, Faster DON Test
Tweet
Share
E-mailGet Alerts NEOG Hot Sheet
Join SI Premium – FREE
Neogen Corporation (Nasdaq: NEOG) has developed a new test for deoxynivalenol (DON) that combines the speed and simplicity of a lateral flow test with the fully quantitative precision of a more demanding testing method.
The presence of the mold toxin DON in certain grains is a major concern to producers of animal feed and human food.
Neogen's new Reveal Q+ for DON delivers precise results ranging from 0.3 to 6 parts per million (ppm) of DON after only 3 minutes, following an extraction procedure that only requires water. Reveal Q+ test strips are read in Neogen's AccuScan III lateral flow test reader to deliver exact results.
The presence of the mold toxin DON in certain grains is a major concern to producers of animal feed and human food.
Neogen's new Reveal Q+ for DON delivers precise results ranging from 0.3 to 6 parts per million (ppm) of DON after only 3 minutes, following an extraction procedure that only requires water. Reveal Q+ test strips are read in Neogen's AccuScan III lateral flow test reader to deliver exact results.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- Nuvectis Pharma (NVCT) files $200M mixed shelf
- Home Depot expands executive roles, grants $500K in restricted stock
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
